id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-E-0093-0008,FDA,FDA-2008-E-0093,U.S. Patent and Trademark Office to Bristol Myers Squibb Co. - Letter,Other,Letter(s),2012-06-05T04:00:00Z,2012,6,2012-06-05T04:00:00Z,,2012-06-05T12:46:55Z,,0,0,0900006481030dec
FDA-2008-E-0093-0007,FDA,FDA-2008-E-0093,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2009-06-05T04:00:00Z,2009,6,2009-06-05T04:00:00Z,,2009-06-05T13:42:39Z,,0,0,09000064809c4b8c
FDA-2008-E-0093-0006,FDA,FDA-2008-E-0093,Determination of Regulatory Review Period for Purposes of Patent Extension; IXEMPRA,Notice,N-Notice,2008-11-10T05:00:00Z,2008,11,2008-11-10T05:00:00Z,2009-01-10T04:59:59Z,2008-11-10T13:02:42Z,E8-26678,0,0,09000064807a13b2
FDA-2008-E-0093-0004,FDA,FDA-2008-E-0093,USPTO to FDA/CDER - Letter,Other,LET-Letter,2008-10-22T04:00:00Z,2008,10,2008-10-22T04:00:00Z,,2008-10-22T19:21:56Z,,0,0,09000064806f8f16
FDA-2008-E-0093-0005,FDA,FDA-2008-E-0093,FDA/CDER to the USPTO - Letter,Other,LET-Letter,2008-10-22T04:00:00Z,2008,10,2008-10-22T04:00:00Z,,2008-10-22T19:21:58Z,,0,0,0900006480773053
FDA-2008-E-0093-0003,FDA,FDA-2008-E-0093,FDA/CDER to USPTO - Letter,Other,LET-Letter,2008-10-22T04:00:00Z,2008,10,2008-10-22T04:00:00Z,,2008-10-22T19:21:55Z,,0,0,0900006480523050
FDA-2008-E-0093-0001,FDA,FDA-2008-E-0093,Bristol-Myers Squibb Co. - Patent Term Extension Application,Other,APP-Application,2008-02-11T05:00:00Z,2008,2,2008-02-11T05:00:00Z,,2008-10-22T19:16:29Z,,0,0,09000064803a93b1
FDA-2008-E-0093-0002,FDA,FDA-2008-E-0093,USPTO - Letter,Other,LET-Letter,2008-02-11T05:00:00Z,2008,2,2008-02-11T05:00:00Z,,2008-10-22T19:16:56Z,,0,0,09000064803a93e8